FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diazepam Injection, USP
Status: Currently in Shortage
»Date first posted: 09/22/2017
»Therapeutic Categories: Neurology

Expand all

Hospira, Inc. (Revised 02/28/2019)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/2 mL (5 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1273-32) Next Delivery: April 2019; Estimated Recovery: September 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Special Handling Instructions per DHCP Letter
50 mg/10 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-3213-12) Available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English